论文部分内容阅读
目的针对新生儿肺炎患儿采用盐酸氨溴索进行治疗,并分析治疗效果。方法 86例新生儿肺炎患儿,随机分成试验组与对照组,每组43例。对照组给予常规治疗,试验组在常规治疗基础上静脉滴注盐酸氨溴索,比较两组患儿治疗后的症状改善时间、住院时间与总有效率。结果治疗后试验组患儿的症状改善时间及住院时间均少于对照组,且试验组患儿治疗后总有效率(97.67%)明显高于对照组(69.77%),差异均具有统计学意义(P<0.05)。结论新生儿肺炎采用盐酸氨溴索进行治疗的疗效相对于传统的治疗方法具有明显的优势,建议广泛使用。
Objective To treat patients with neonatal pneumonia with ambroxol hydrochloride and analyze the therapeutic effect. Methods A total of 86 neonates with pneumonia were randomly divided into experimental group and control group, with 43 cases in each group. The control group was given conventional treatment. The experimental group received ambroxol hydrochloride intravenously on the basis of routine treatment. The improvement time, hospitalization time and total effective rate of the two groups were compared. Results After treatment, the symptom improvement time and hospitalization time in the experimental group were less than those in the control group, and the total effective rate (97.67%) in the experimental group was significantly higher than that in the control group (69.77%), the differences were statistically significant (P <0.05). Conclusion The efficacy of ambroxol hydrochloride for neonatal pneumonia has obvious advantages over the traditional treatment methods, and it is suggested that it should be widely used.